If your antibody levels drop over time... it's not the end of the world. Actually, it's what happens naturally. It's expected. It's your body being economical with its resources. 1/

theatlantic.com/science/archiv…
There are so many other immune cells and molecules protecting you; antibodies aren't the whole story.

But if you're worried about antibodies specifically—which, yes, are powerful and important and do play a big role in protection— 2/

theatlantic.com/science/archiv…
Think of it this way. Antibodies are ephemeral proteins. Individual antibodies aren't built to last forever. They'll ebb after an infectious threat has passed. But the body retains the capacity to produce them. 3/
Fretting over a drop in antibody titers is like panicking over a restaurant that isn't grilling 400 steaks every hour of every single day.

Maybe sometimes they hit peak output—but it's based on NEED. More patrons, more cooking.

Grilling for an empty room is a waste. 4/
And yet, even when those topline chefs aren't cooking, they retain the capacity to do so. They remember the recipes. They still have the cookware and the raw meat. And they can whip what you need in a jiffy, because they're pros. 5/
For perspective - yes, there are viruses to which we keep churning out measurable levels of antibodies for a lifetime, even without them visiting us again.

But there are also some for which we *don't*, and we're still protected. 6/
If you take a hepatitis B antibody test years after you've been vaccinated and it's negative, for example, that's actually no cause for alarm. Studies have shown that the vast majority of these people are still protected. 7/
That's because B cells in the body—the cells that make antibodies—immediately leap into action if they see the actual virus, and make more antibodies. It's fast enough that these people are still considered protected. 8/
(Health care workers may get boosters if their HBV antibody tests are negative, but this is an intentionally overcautious approach. They are at high risk because of their job.) 9/
We can't yet reliably "measure immunity" to the coronavirus. When thinking about vaccine efficacy, look to data from real people, and whether they're getting sick for the best info—not tests done on molecules in labs. 10/10

theatlantic.com/science/archiv…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Katherine J. Wu, Ph.D.

Katherine J. Wu, Ph.D. Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @KatherineJWu

30 Jul
howdy!

remember Ct values? those numbers spit out by certain types of PCR tests, including some of the ones we use to test for the coronavirus?

let's talk. 1/
Ct values correlate with how much viral RNA is in the sample. so if you're running several samples on a test platform, and some have higher Cts, those have *less* RNA (it's a reverse scale; Cts count how many times you have to copy the genetic material before it's "visible") 2/
Ct values do not tell you if the viral RNA belongs to an intact virus or an infectious virus. they also don't measure how directly "transmissible" someone is. to measure transmission, we need epidemiological data - how are *actual humans* spreading the virus? 3/
Read 5 tweets
29 Jul
This week, I wrote a piece about the importance of studying the cat genome.

I think there are some important implications for human health. But I am also hopeful that this will mean big advancements for veterinary medicine. 1/

theatlantic.com/science/archiv…
The day this piece published, one of my own cats, Calvin, was diagnosed with a serious condition, likely with genetic roots, that impacts his heart function. There is no cure. We don't yet know his prognosis. I am absolutely heartbroken. 2/
We adopted Calvin and his brother, Hobbes, almost 5 years ago, to the day. Since then, they have both brought immeasurable light into my life, and have been my biggest source of comfort during the pandemic. 3/
Read 9 tweets
22 Jul
There's been a renewed wave of coverage on breakthroughs (post-vaccination infections), so I thought I'd do a brief thread.

Breakthroughs aren't new. They're also expected. Researchers saw them coming. Here's why they happen. 1/

theatlantic.com/science/archiv…
Let's first get our definitions straight. Vaccines, first and foremost, prevent *illness*, especially of the serious sort. They teach the body to rein the virus in, and keep it from running roughshod over your tissues. It's harder, though, to stop infections entirely. 2/
Remarkably, our vaccines do this in some people! That's worth celebrating, but it's the wrong goalpost to have in most cases.

That said, our vaccines are still REDUCING infection and transmission, even if they're not stamping it out. 3/
Read 13 tweets
22 Jul
I feel great about being fully vaccinated. I still want to give my immune system the best chance it's got at protecting me from disease. 1/

theatlantic.com/health/archive…
I laid out some of my thinking process for masking again indoors, in the age of Delta. This is my own personal risk calculation, but I hope it's helpful for some other folks who are puzzling this over. 2/
There's no *one right answer*—rather, everyone has to think about their own local conditions: hospitalizations, vaccination rates, variant prevalence, etc. But it would serve us all to be flexible. This pandemic isn't over. And I don't want to lose the momentum we've built. 3/
Read 4 tweets
20 Jul
a gentler reminder that there's more to vaccine effectiveness than neutralizing antibodies
get to know some of your other (very date-able) defenders here
theatlantic.com/science/archiv…
and remember that the immune system is used to dealing with changes in the pathogens it sees

theatlantic.com/science/archiv…
Read 4 tweets
13 Apr
I am not an MD, so I’ll offer just this: it’s very encouraging to see federal regulators take swift action on the J&J vaccine. This is the process working as it should. If there is a true link between the vaccine and these rare clots, they will work to identify it. 1/
They may instate an age restriction, as some countries have done for the similar AstraZeneca vaccine—perhaps younger people, especially younger people who are biologically female, may end up needing to seek an alternative. But for now: these cases appear VERY RARE. 2/
So far less than 1 in 1 million. And this DOES NOT detract from the effectiveness of the vaccine, which is excellent.

If you have gotten this vaccine, keep those numbers in mind. All clots also appeared within 2 weeks of injection. 3/
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(